Apex Healthcare Bhd (XKLS:7090) ROCE %: 10.50% (As of Sep. 2025)


XKLS:7090 Apex Healthcare Bhd XKLS:7090
63 GF Score
Price RM2.61
GF Value RM2.27
! 7 Warning Signs
View Full Analysis

What is Apex Healthcare Bhd ROCE %?

Apex Healthcare Bhd XKLS:7090 63 ROCE % is 10.50% as of Sep. 2025. GuruFocus rates XKLS:7090 with a GF Score™ of 63/100 and a GF Value™ of RM2.27. The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Apex Healthcare Bhd's annualized ROCE % for the quarter that ended in Sep. 2025 was 10.50%.

Apex Healthcare Bhd  (XKLS:7090) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Apex Healthcare Bhd ROCE % Related Terms

Apex Healthcare Bhd ROCE % Historical Data

* Premium members only.

The historical data trend for Apex Healthcare Bhd's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apex Healthcare Bhd ROCE % Chart

Apex Healthcare Bhd Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.26 15.13 21.96 56.27 11.54

Apex Healthcare Bhd Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.57 10.62 10.88 11.67 10.50
XKLS:7090
63GF Score
Apex Healthcare Bhd XKLS:7090
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apex Healthcare Bhd ROCE % Calculation

Apex Healthcare Bhd's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=102.606/( ( (1122.617 - 190.598) + (1008.886 - 163.013) )/ 2 )
=102.606/( (932.019+845.873)/ 2 )
=102.606/888.946
=11.54 %

Apex Healthcare Bhd's ROCE % of for the quarter that ended in Sep. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2025 )  (Q: Jun. 2025 )(Q: Sep. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2025 )  (Q: Jun. 2025 )(Q: Sep. 2025 )
=88.7/( ( (1018.416 - 159.695) + (998.296 - 166.87) )/ 2 )
=88.7/( ( 858.721 + 831.426 )/ 2 )
=88.7/845.0735
=10.50 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 10.50% mean?
Apex Healthcare Bhd (XKLS:7090) has a ROCE % of 10.50% as of Sep. 2025.
Is Apex Healthcare Bhd's ROCE % too high?
Apex Healthcare Bhd's current ROCE % is 10.50%. The Medical Distribution industry median ROCE % is 9.22. Apex Healthcare Bhd's value of 10.50% is 13.9% above this industry median. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's ROCE % compare to MCK and COR?
Apex Healthcare Bhd's ROCE % of 10.50% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.22. Apex Healthcare Bhd's value of 10.50% is 13.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 9.22, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apex Healthcare Bhd's current ROCE % of 10.50% is 13.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apex Healthcare Bhd's current ROCE % is 10.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current ROCE % of 10.50%. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current ROCE % is 10.50% and 13.9% above the Medical Distribution industry median of 9.22. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current ROCE % is 10.50% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?

Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued. The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.

Key valuation signals for XKLS:7090:

  • ROCE %: 10.50%
  • GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
  • GF Score™: 63/100 with 7 warning signs
  • Industry Position: 13.9% above the Medical Distribution median

No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Apex Healthcare Bhd Business Description

Address 1-5 Jalan TTC 1, Cheng Industrial Estate, Melaka, MLA, MYS, 75250
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score

Get the complete analysis for XKLS:7090

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM2.61
Price
RM2.27
GF Value